Skip to main content

Day: March 17, 2025

Rekor Systems Provides Guidance on Financial Results and Updates on Operational and Management Realignments

Realignment of Development and Product Distribution Efforts Focuses on Accelerating Cash Flow Performance COLUMBIA, Md., March 17, 2025 (GLOBE NEWSWIRE) — Rekor Systems, Inc. (NASDAQ: REKR), a global leader in roadway intelligence, today provided insights into its preliminary year-end 2024 results and recent actions to improve financial performance by reducing the level of operating losses while positioning the Company for growth both domestically and internationally. Based on preliminary and unaudited financial results, full-year 2024 revenue is expected to be above $45.5 million, representing a year-over-year increase above 30% compared to 2023. Fourth-quarter 2024 revenue is projected to be above $12.5 million, reflecting growth above 12% compared to the same period last year. The following table sets forth the components of...

Continue reading

NFI subsidiary New Flyer secures two Maryland Transit Administration orders for a total of 117 low- and zero-emission Xcelsior® buses

ST. CLOUD, Minn., March 17, 2025 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leader in propulsion agnostic bus and coach mobility solutions, subsidiary New Flyer of America Inc. (New Flyer), today announced new firm orders from the Maryland Transit Administration (the agency) for a total of 117 buses (127 equivalent units or EUs). These awards consist of:50 Xcelsior® 40-foot hybrid-electric buses (50 EUs) and 20 Xcelsior CHARGE NG™ 40-foot battery-electric buses (20 EUs) awarded in the fourth quarter of 2024. An additional 37 Xcelsior 40-foot hybrid-electric buses (37 EUs), and 10 Xcelsior CHARGE NG 60-foot battery-electric buses (20 EUs) awarded in the first quarter of 2025.The combination of orders further solidifies New Flyer’s role in delivering sustainable, high-performance transit...

Continue reading

Auction result of Treasury Bills – RIKV 25 0521 – RIKV 25 0917

Series  RIKV 25 0521 RIKV 25 0917Settlement Date  03/19/2025 03/19/2025Total Amount Allocated (MM)  8,536 21,342All Bids Awarded At (Price / Simple interest)  98.611 / 8.049 96.089 / 8.051Total Number of Bids Received  14 23Total Amount of All Bids Received (MM)  9,836 22,742Total Number of Successful Bids  12 21Number of Bids Allocated in Full  12 21Lowest Price / Highest Simple Interest Allocated  98.611 / 8.049 96.089 / 8.051Highest Price / Lowest Simple Interest Allocated  98.647 / 7.837 96.216 / 7.779Lowest Price / Highest Simple Interest Allocated in Full  98.611 / 8.049 96.089 / 8.051Weighted Average of Successful Bids (Price/Simple Interest)  98.630 / 7.937 96.144 / 7.933Best Bid (Price / Simple Interest)  98.647 / 7.837 96.216 / 7.779Worst Bid (Price / Simple Interest)  98.602 / 8.102 96.066 / 8.100Weighted...

Continue reading

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Significant progress was made in 2024, including refining the Phase 3 program to accelerate rilparencel’s path to market in the U.S., the release of positive Phase 2 data, restarting manufacturing, and securing $140 million of equity to extend cash runway into mid-2027 In Q4 2024, the FDA confirmed in a Type B meeting that the accelerated approval pathway is available for rilparencel if an acceptable surrogate endpoint, which may include eGFR slope, is used; additional details expected in mid-2025 Full data from Group 1 in the Phase 2 REGEN-007 study expected in Q2 2025; interim data from June 2024 showed kidney function stabilization for 18 months in patients with advanced CKD and diabetes Ended the fourth quarter with $358 million in cash and cash equivalents and marketable securities, supporting operations into mid-2027WINSTON-SALEM,...

Continue reading

BitFuFu to Report Full Year 2024 Financial Results on March 25, 2025

SINGAPORE, March 17, 2025 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a global leader in Bitcoin mining and comprehensive mining services, today announced that it will release its full year financial results for the year ended December 31, 2024, before U.S. markets open on March 25, 2025. The Company’s management team will hold an earnings conference call at 8:00 A.M. U.S. Eastern Time on Tuesday, March 25, 2025 (8:00 P.M. Singapore Time on the same day). All participants must register in advance of the conference call using the link provided below. Upon registration, each participant will receive a confirmation email containing dial-in numbers and a unique access PIN, which will be used to join the conference call. Registration Link: https://edge.media-server.com/mmc/p/psxtq5kh Additionally, a...

Continue reading

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, entered into a collaboration and license agreement to advance into the clinic the first oral dual agonist GLP-1/glucagon peptide as a once-daily tablet treatment for patients with obesity, metabolic and fibrotic disorders. The program combines OPKO’s proprietary long-acting oxyntomodulin analog (OPK-88006) and Entera’s proprietary N-Tab™ technology. Favorable pharmacodynamic, pharmacokinetic and bioavailability data in vivo were reported in September 2024. The companies expect to file an Investigational New Drug application with the U.S. Food and Drug Administration (FDA) later this year. Under the terms of the agreement,...

Continue reading

Microchip Introduces Electric Two-Wheeler Ecosystem to Accelerate E-Mobility Innovation

Scalable and flexible solutions to design diverse models of e-scooters and e-bikes CHANDLER, Ariz., March 17, 2025 (GLOBE NEWSWIRE) — The electric two-wheeler market is transforming the transportation industry as consumers embrace e-scooters and e-bikes for both recreational use and daily commuting. Microchip Technology (Nasdaq: MCHP) today announces the launch of its Electric Two-Wheeler (E2W) ecosystem, a comprehensive suite of pre-validated reference designs that addresses key challenges in e-scooter and e-bike development, including power efficiency, system integration, safety and time-to-market. By offering automotive-grade, scalable solutions, Microchip enables manufacturers to streamline development and build reliable, feature-rich electric two-wheelers. Microchip’s automotive-grade components and modular reference designs...

Continue reading

Tiziana Life Sciences to Present at the 37th Annual Roth Conference

NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that the CEO of Tiziana Life Sciences, Ivor Elrifi, will be presenting during a fireside chat at the 37th Annual ROTH Conference and host 1×1 investor meetings. The Conference is being held March 16-18, 2025, in Dana Point, California. This year’s event will consist of 1-on-1 / small group meetings, analyst-selected fireside chats, industry keynotes and panels with executive management attending from approximately 450 private and public companies in a variety of growth sectors. Presentation Details:Date: Tuesday, March...

Continue reading

MicroCloud Hologram Inc. Researches CV-QNN (Continuous Variable Quantum Neural Networks) Technology and Builds Variational Quantum Circuits Embedded in CV Architecture

SHENZHEN, China, March 17, 2025 (GLOBE NEWSWIRE) — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, they are researching CV-QNN (Continuous Variable Quantum Neural Networks) technology, with the aim of building Variational Quantum Circuits embedded in CV architecture. In this way, it is possible not only to quantumize classical neural networks, but also to design various specialized quantum models, such as convolutional quantum networks, recursive quantum networks, and residual quantum networks, providing new tools for quantum artificial intelligence technology. The core of HOLO CV-QNN lies in achieving affine transformations and nonlinear mappings in neural networks through layered continuously parameterized quantum gates and nonlinear activation functions. The CV architecture...

Continue reading

BigCommerce Transforms Commerce Beyond Order Capture with Pipe17 Partnership

Agreement extends Pipe17’s connectivity network to BigCommerce and Feedonomics customers to reach critical fulfillment endpoints AUSTIN, Texas, March 17, 2025 (GLOBE NEWSWIRE) — BigCommerce (Nasdaq: BIGC), a leading provider of open, composable commerce solutions for B2C and B2B brands, retailers, manufacturers and distributors today announced a transformational partnership with Pipe17, a leading provider of AI-powered composable order operations. This partnership reimagines how modern merchants manage orders in an increasingly complex digital commerce ecosystem. BigCommerce empowers brands, retailers, manufacturers and distributors of all sizes to sell online and capture orders seamlessly. Feedonomics, BigCommerce’s AI-powered product data feed management and order orchestration solution, helps brands list, manage and optimize...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.